Influence of the new herbal remedy containing dry extracts of White Mulberry leaves, Common Bean shells and Blueberry shoots on blood lipids if experimental Type 2 Diabetes Mellitus

Authors

DOI:

https://doi.org/10.24959/ubphj.19.211

Keywords:

cholesterol, dislipoproteinemia, diabetes mellitus, white mulberry (Morus alba L.), common beans (Phaseolus vulgaris L.), blueberry (Vaccinium myrtillus L.)

Abstract

Topicality. A rapid trend towards the incidence and prevalence of diabetes has created an alarming situation around the world. Complex treatment for patients with diabetes with dislipoproteinemia should include agents that will affect all metabolic disorders, including changes in lipid metabolism, which will provide for the prevention of vascular
complications.
Aim. To determine the specific activity of the new herbal remedy by comparing the lipid metabolism indices with the experimental model of type 2 diabetes induced by the introduction of streptozotocin with the prior nicotinamide administration.
Materials and methods. A type 2 diabetes mellitus was reproduced by administering streptozotocin with prior nicotinamide administration to mature male rats. The aqueous solutions of investigational agents were administered intragastrically for four weeks, after which the parameters of the lipid blood spectrum were determined.
Results and discussion. Herbal remedy reliably reduces the concentration of total lipids, total cholesterol, triglycerides, low and very low-density lipoprotein compared to the control group in the experimental model of type 2 diabetes. Such changes led to a significant decrease in the atherogenicity coefficient – by 37.7 % relative to the control group, which was 13.8 % and 10.9 % lower than the reference groups that received the infusion of Arfazetin and metformin respectively.
Conclusions. The obtained results indicate the further research feasibility into the possibility of using the new phytoplankton for the prevention and treatment of type 2 diabetes and diabetic dislipoproteinemia.

Author Biographies

A. I. Dub, Horbachevsky Ternopil State Medical University, Ternopil

graduate student, senior laboratory assistant of the Department of Pharmacy Management, Economics and Technology

I. M. Klishch, Horbachevsky Ternopil State Medical University, Ternopil

Doctor of Biological Sciences, professor of the Department of Functional and Laboratory Diagnostics

References

IDF Diabetes Atlas, 8–th edition. (2017). Brussels, Belgium: International Diabetes Federation, 144. Availble at: http://www.diabetesatlas.org/

Ahangarpour, A., Heidari, H., Oroojan, A. A., Mirzavandi, F., Esfehani, K. N., Mohammadi, Z. D. (2017). Antidiabetic, hypolipidemic and hepatoprotective effects of Arctium lappa root’s hydro-alcoholic extract on nicotinamide–streptozotocin induced type 2 model of diabetes in male mice. Avicenna journal of phytomedicine, 7 (2), 169–179.

Mustafa, S. B., Mehmood, Z., Akhter, N., Kauser, A., Hussain, I., Rashid, A., Niazi, S. G. (2016). Medicinal plants and management of Diabetes Mellitus: A review. Pak. J. Pharm. Sci, 29 (5), 1885–1891.

Shebaldova, K. O., & Komisarenko, Y. I. (2018). Clinical experience of using herbal medicinal product Glucemedin in the comprehensive treatment of patients with type 2 diabetes mellitus. International journal of endocrinology, 14 (5), 462–468. https://doi.org/10.22141/2224-0721.14.5.2018.142681

Urbanovych, A. M., Susyk, G. I., Urbanovych, M. O. (2018). Zdobutky klinichnoi i eksperymentalnoi medytsyny, 2, 129–134. https://doi.org/10.11603/1811-2471.2018.v0.i2.8637

Serhiienko, V. O. (2012). Zhurnal NAMN Ukrainy, 18 (2), 205–216.

Chernatska, O. M., Chernatskaia, O. N. (2018). Zhurnal klinichnykh ta eksperymentalnykh medychnykh doslidzhen, 6 (2), 238–244.

Mooradian, A. D. (2009). Dyslipidemia in type 2 diabetes mellitus. Nature Reviews Endocrinology, 5 (3), 150–159. https://doi.org/10.1038/ncpendmet1066

Duvnjak, L., & Blaslov, K. (2016). Dipeptidyl peptidase-4 inhibitors improve arterial stiffness, blood pressure, lipid profile and inflammation parameters in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome, 8 (1). https://doi.org/10.1186/s13098-016-0144-6

Lukashiv, O. Ya. (2018). Naukovi zapysky Ternopilskoho natsionalnoho pedahohichnoho universytetu imeni Volodymyra Hnatiuka. Seriia : Biolohiia, 1, 119–122.

DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., … Simonson, D. C. (2015). Type 2 diabetes mellitus. Nature reviews Disease primers, 1, 15019.

Dub, A. I., Klishch, I. M., Vronska, L. V., Stechyshyn, I. P. (2018). Colloquium – journal, 11(22), 32–41.

Dub, A. I., Klishch, I. M., Vronska, L.V., Stechyshyn, I. P. (2018). Farmakolohiia i likarska toksykolohiia, 4–5, 32–37.

Dub, A. I., Klishch, I. M., Vronska, L. V., Stechyshyn, I. P. (2018). Medychna i klinichna khimiia, 3, 43–49. https://doi.org/10.11603/mcch.2410-681x.2018.v0.i3.9313

Islam, M., Choi, H. (2007). Nongenetic model of type 2 diabetes: a comparative study. Pharmacology, 79 (4), 243–249. https://doi.org/10.1159/000101989

Mironov, A. N., Buniatian, N. D., Vasilev, A. N., Verstakova, O. L., Zhuravleva, M. V., Lepakhin, V. K., Uteshev, D. B. (2012). Rukovodstvo po provedeniiu doklinicheskikh issledovanii lekarstvennykh sredstv. M. : Grif i K, 944.

Stefanov, A. V. (2002). Doklinicheskie issledovaniia lekarstvennykh sredstv: Metodicheskie rekomendatcii. Kyiv : Avitcenna, 568.

Klevanova, V. S. (2016). Hipohlikemichna ta hipolipidemichna diia ekstraktu pidzemnykh orhaniv chornoholovnyka rodovykovoho (Poterium sanguisorba L.). Extended abstract of candidate’s thesis. Zaporizhzhia, 171.

Lukashiv, O. Ya., Bodnar, O. I., Hrubinko, V. V. (2017). Naukovi zapysky Ternopilskoho natsionalnoho pedahohichnoho universytetu imeni Volodymyra Hnatiuka. Seriia : Biolohiia, 64–70.

Downloads

Published

2019-05-29

Issue

No. 2(59) (2019)

Section

Pharmacology and biochemistry

License

Copyright (c) 2019 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).